Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Inflammatory bowel diseases
1
Duodenal Crohn's disease: Case report and systematic review
3/7/2024 9:32:28 AM |
Browse: 63 |
Download: 70
2
Cardiovascular implications of inflammatory bowel disease: An updated review
11/23/2023 8:41:50 AM |
Browse: 87 |
Download: 123
3
Spatial cluster mapping and environmental modeling in pediatric inflammatory bowel disease
6/16/2023 9:52:18 AM |
Browse: 143 |
Download: 439
4
Cytotoxic synergism of Clostridioides difficile toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases
1/20/2023 1:48:20 PM |
Browse: 210 |
Download: 390
5
Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology
1/6/2023 2:52:58 AM |
Browse: 197 |
Download: 372
6
Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease
12/27/2022 10:06:45 AM |
Browse: 200 |
Download: 415
7
Evaluation of gut dysbiosis using serum and fecal bile acid profiles
12/2/2022 12:50:19 PM |
Browse: 198 |
Download: 361
8
Role of short chain fatty acids in gut health and possible therapeutic approaches in inflammatory bowel diseases
9/27/2022 1:00:17 PM |
Browse: 296 |
Download: 861
9
Strategies to improve the effect of mesenchymal stem cell therapy on inflammatory bowel disease
9/23/2022 9:45:22 AM |
Browse: 305 |
Download: 757
10
Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil
8/10/2022 8:23:14 AM |
Browse: 361 |
Download: 1102
11
Shared decision-making in the management of patients with inflammatory bowel disease
7/13/2022 7:30:59 AM |
Browse: 289 |
Download: 599
12
Novel drug delivery systems for inflammatory bowel disease
5/12/2022 8:42:29 AM |
Browse: 353 |
Download: 827
13
c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions
3/30/2022 3:20:26 PM |
Browse: 356 |
Download: 549
14
“Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel disease”: A letter to the editor
2/24/2022 9:46:00 AM |
Browse: 341 |
Download: 555
15
Mammalian target of rapamycin; novel insight for management of inflammatory bowel diseases
1/25/2022 7:27:40 AM |
Browse: 475 |
Download: 953
16
Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders
12/27/2021 5:24:00 AM |
Browse: 343 |
Download: 534
17
Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment
12/10/2021 9:08:48 AM |
Browse: 381 |
Download: 886
18
Enteric nervous system and inflammatory bowel diseases: Correlated impacts and therapeutic approaches through the P2X7 receptor
12/10/2021 9:08:48 AM |
Browse: 367 |
Download: 568
19
Influence of nutritional status in the postoperative period of patients with inflammatory bowel disease
9/3/2021 8:21:31 AM |
Browse: 440 |
Download: 854
20
Viral infections in inflammatory bowel disease: Tips and tricks for correct management
7/19/2021 2:10:40 PM |
Browse: 424 |
Download: 914
21
Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil
6/18/2021 5:06:16 AM |
Browse: 482 |
Download: 1413
22
Receptor for advanced glycation end-products axis and COVID-19 in inflammatory bowel diseases: A dangerous liaison?
5/13/2021 10:05:39 AM |
Browse: 365 |
Download: 688
23
Risk stratification and geographical mapping of Brazilian inflammatory bowel diseases patients during COVID-19 outbreak: Results from a nationwide survey
3/25/2021 11:42:15 AM |
Browse: 514 |
Download: 1433
24
Helicobacter pylori: Commensal, symbiont or pathogen?
2/20/2021 2:51:13 AM |
Browse: 716 |
Download: 1163
25
Assessment of disease activity in inflammatory bowel diseases: Non-invasive biomarkers and endoscopic scores
12/13/2020 7:01:09 AM |
Browse: 623 |
Download: 1336
26
Primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome associated with inflammatory bowel disease: A case report and systematic review
9/22/2020 3:17:13 AM |
Browse: 633 |
Download: 1574
27
Potential of the ellagic acid-derived gut microbiota metabolite – Urolithin A in gastrointestinal protection
6/21/2020 2:15:44 PM |
Browse: 800 |
Download: 1316
28
Cytapheresis for pyoderma gangrenosum associated with inflammatory bowel disease: A review of current status
6/8/2020 3:14:59 AM |
Browse: 696 |
Download: 1033
29
Increased circulating circular RNA_103516 is a novel biomarker for adult inflammatory bowel disease
11/7/2019 1:35:59 AM |
Browse: 715 |
Download: 1779
30
Cell membrane and bioactive factors derived from mesenchymal stromal cells: Cell-free based therapy for inflammatory bowel diseases
9/25/2019 3:03:24 AM |
Browse: 689 |
Download: 1092
31
Role of NLRP3 inflammasome in inflammatory bowel diseases
9/7/2019 4:43:36 AM |
Browse: 739 |
Download: 1043
32
Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment
8/21/2019 9:19:18 AM |
Browse: 818 |
Download: 1345
33
Inflammatory bowel disease patient profiles are related to specific information needs: A nationwide survey
8/14/2019 1:31:33 PM |
Browse: 703 |
Download: 1480
34
Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases
8/14/2019 1:31:33 PM |
Browse: 825 |
Download: 1164
35
Bone alterations in inflammatory bowel diseases
8/6/2019 11:50:46 AM |
Browse: 894 |
Download: 1185
36
Has the time been reached for pseudopolyps to be re-enrolled in endoscopic inflammatory bowel disease scores?
6/14/2019 9:31:26 AM |
Browse: 769 |
Download: 957
37
Nutritional status as a predictor of hospitalization in inflammatory bowel disease: A review
3/7/2019 5:00:17 AM |
Browse: 911 |
Download: 1255
38
Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review
3/7/2019 3:51:24 AM |
Browse: 997 |
Download: 1310
39
Vitamin D therapy in children with inflammatory bowel disease: A systematic review
1/22/2019 9:48:23 AM |
Browse: 875 |
Download: 1178
40
Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis
10/12/2018 5:32:21 AM |
Browse: 1022 |
Download: 1409
41
Web-based learning in inflammatory bowel diseases: General truths and current specifics
9/28/2018 10:31:14 AM |
Browse: 884 |
Download: 1168
42
From bench to bedside: fecal calprotectin in inflammatory bowel diseases clinical setting
9/6/2018 1:33:44 AM |
Browse: 926 |
Download: 1451
43
Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models
5/6/2018 1:12:00 PM |
Browse: 1045 |
Download: 1273
44
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study
10/21/2017 7:10:38 AM |
Browse: 828 |
Download: 1563
45
Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology
9/25/2017 8:56:57 AM |
Browse: 1012 |
Download: 1682
46
Helminths as an alternative therapy for intestinal diseases
9/7/2017 8:51:55 AM |
Browse: 1057 |
Download: 1460
47
Prognostic significance of red blood cell distribution width in gastrointestinal disorders
7/20/2017 10:12:50 AM |
Browse: 1280 |
Download: 1478
48
P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers
3/6/2017 1:27:00 PM |
Browse: 969 |
Download: 1571
49
Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases
12/19/2016 8:28:00 PM |
Browse: 1166 |
Download: 1474
50
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?
12/13/2016 12:40:00 AM |
Browse: 1321 |
Download: 1650
Page 1 of 2 ( 87 items )
<<
1
2
>>
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345